| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/19/2009 | CN100528180C Medication for treating diseases of cranial nerve and cerebrovascular, and preparation method |
| 08/19/2009 | CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof |
| 08/19/2009 | CN100528171C Oil-in-water baicalin nano-milk oral liquid and its preparing process |
| 08/19/2009 | CN100528166C Portal hypertension inhibitor |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/19/2009 | CN100528153C Percutaneous absorption type cerebral protective agent |
| 08/19/2009 | CN100528152C 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576064 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 08/18/2009 | US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 08/18/2009 | US7576050 Glucagon-like peptides and ependins for use in treatment and prevention of diabetes and neurodegenerative conditions; neuroprotective agents; neurotrophic factors |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |
| 08/18/2009 | US7575857 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy |
| 08/18/2009 | US7575577 Devices and methods for the restoration of a spinal disc |
| 08/18/2009 | US7575547 Cardiac support device with anti-fibrosis coating |
| 08/18/2009 | CA2585557C Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/18/2009 | CA2577233C Pharmaceutical composition containing angiotensin ii antagonist |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2315141C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof |
| 08/18/2009 | CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product |
| 08/14/2009 | CA2654210A1 Association of a sinus current inhibitor if and a beta blocker |
| 08/13/2009 | WO2009100435A2 Sclerotherapy for varicose veins |
| 08/13/2009 | WO2009100250A1 Chromene derivatives and use thereof as hif hydroxylase activity inhibitors |
| 08/13/2009 | WO2009099676A1 Type 5 adenylyl cyclase inhibitors for providing cardiac protection |
| 08/13/2009 | WO2009099489A2 Compositions and methods for improving cardiovascular health |
| 08/13/2009 | WO2009099221A1 Production method and production device for composition having high content of theobromine |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098901A1 3,8-diaminotetrahydroquinoline derivative |
| 08/13/2009 | WO2009098279A1 Protective effect of high dose folate on mycardial ischemia |
| 08/13/2009 | WO2009098276A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | WO2009098275A1 Substituted piperidines as renin inhibitors |
| 08/13/2009 | WO2009098113A1 Nitric oxide donor compounds |
| 08/13/2009 | WO2009097991A1 Substituted furans and use thereof |
| 08/13/2009 | WO2009097893A1 Methods for the treatment of cardiac disease associated to myocardial fibrosis using an inhibitor of pcp |
| 08/13/2009 | WO2009097691A1 USE OF P27kip1 FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| 08/13/2009 | WO2009072132A3 Beta glycolipids for the treatment of calcification related degenerative disorders |
| 08/13/2009 | WO2009052972A3 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 08/13/2009 | WO2009050201A3 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 08/13/2009 | WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043453A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009039964A3 Use of glucagon-like peptide as a therapeutic agent |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009033770A3 Calcitonin c-terminal flanking peptide for use as a therapeutic agent |
| 08/13/2009 | WO2008071081A8 Preparation of low bleeding anticoagulant fusion protein and its use |
| 08/13/2009 | WO2005122682A3 Process for the preparation of esters of piperazic acid |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090204104 Methods for Compounding and Delivering a Therapeutic Agent to the Adventitia of a Vessel |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203793 Compounds for the treatment of metabolic disorders |
| 08/13/2009 | US20090203778 Fatty acid analogues, i.e. including dha derivatives for uses as a medicament |
| 08/13/2009 | US20090203769 Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling |
| 08/13/2009 | US20090203768 Nucleic acid-containing complex |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203765 Modulation of eif4e-bp2 expression |
| 08/13/2009 | US20090203761 Process for preparing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203758 angiotensin converting enzyme inhibitors, used for the treatment of congestive heart failure aand as hypotensive agents; dissolving perindopril and L-arginine in water, adding apolar and polar solvents, then filtering, washing and drying the crystals obtained |
| 08/13/2009 | US20090203752 Compounds for nonsense suppression, and methods for their use |
| 08/13/2009 | US20090203739 Anti-Inflammatory Agents |
| 08/13/2009 | US20090203734 F1f0-atpase inhibitors and related methods |
| 08/13/2009 | US20090203732 Thiazolones for Use as P13 Kinase Inhibitors |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics |
| 08/13/2009 | US20090203695 Compounds IV |
| 08/13/2009 | US20090203689 Abca-1 elevating compounds and methods |
| 08/13/2009 | US20090203679 Galenical formulations of organic compounds |
| 08/13/2009 | US20090203653 Compositions and Methods Using Apocynin Compounds and Nitric Oxide Donors |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203608 reducing lipid accumulation in an adipocyte; finding a therapeutic agents for treating obesity, diabetes, arteriosclerosis |
| 08/13/2009 | US20090203595 Neuregulin variants and methods of screening and using thereof |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090202664 Herbal cream or oil for the treatment hemorroids and wounds |
| 08/13/2009 | US20090202649 Fenofibrate formulations |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202621 Cell-surface decoration with active agents |
| 08/13/2009 | US20090202566 Use of the ENDO-180 gene and polypeptide for diagnosis and treatment |
| 08/13/2009 | US20090202555 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202535 Method for neutralizing effects of sPLA2 |
| 08/13/2009 | US20090202523 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | US20090202498 Direct differentiation of cardiomyocytes from human embryonic stem cells |
| 08/13/2009 | US20090202491 Method for modulating, regulating and/or stabilizing angiogenesis |
| 08/13/2009 | US20090202467 Sclerotherapy for varicose veins |
| 08/13/2009 | DE202009006461U1 Kombination von Tocotrienolen mit ungesättigten Fettsäuren als Mittel zum Schutz des Herz/Kreislaufsystems, vor Krebserkrankungen, zur Entzündungshemmung, zur Steigerung der geistigen Leistungsfähigkeit und gegen Altersbeschwerden Combination of tocotrienols with unsaturated fatty acids as a means to protect the heart / circulatory system against cancer, reduces inflammation, increase mental performance and complaints against age |